Interleukin-1β, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-α in chronic sinusitis: Response to systemic corticosteroids

American Journal of Rhinology

Volumn 14, Issue 6, 2000, Pages 367-373

  Lennard, Colleen M ^a   Mann, Eric A ^a   Sun, Leon L ^b   Chang, Audrey S ^a   Bolger, William E ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BIOPSY; CHRONIC SINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOSCOPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; TREATMENT OUTCOME;

EID: 0034453627     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065800779954329     Document Type: Article

References (28)

1. Kennedy DW. First-line management of sinusitis: a national problem? Overview. Otolaryngol Head Neck Surg 103:847, 1990.
2. Bolger WE. Gram negative sinusitis: an emerging clinical entity? Am J Rhinol 8:279-84, 1994.
3. Hsu J, Lanza DC, and Kennedy DW. Antimicrobial resistance in chronic sinusitis. Am J Rhinol, in press.
4. Nadel DM, Lanza DC, and Kennedy DW. Endoscopically guided cultures in chronic sinusitis. Am J Rhinol 12:233-241, 1998.
5. Olsson I, Venge P. The role of the human neutrophil in the inflammatory reaction. Allergy 35:1, 1980.
6. Westrin K.M, and Stiema P. Pathophysiology of sinusitis: Overview and update. In: Aspects on Sinusitis: Diagnosis and Treatment, 1st ed. Stiema P, Karlsson G, Melen I, and Jannert M (Eds). Eli Lilly Sweden AB, 13-21, 1996.
7. Wright ED, Frenkiel S, Al-Ghamdi Khalid, et al. Interleukin-4, interleukin-5, and granulocyte-macrophage colony-stimulating factor receptor expression in chronic sinusitis and response to topical steroids. Otolaryngol Head Neck Surg 118:490-495, 1998.
8. Ghaffar O, Lavigne P, Kamil A, et al. Interleukin-6 expression in chronic sinusitis: colocalization of gene transcripts to eosinophils, macrophages, T lymphocytes, and mast cells. Otolaryngol Head Neck Surg 118:504-511, 1998.
9. Finotto S, Ohno I, Marshall JS, et al. TNF-alpha production by eosinophils in upper airway inflammation (nasal polyposis). J Immunol 153:2278-2288, 1994.
10. Hamilos DL, Leung DY, Huston DP, et al. QGM-CSF, IL-5, and RANTES immunureactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis. Clin Exp Allergy 28:1145-1152, 1998.
11. Hamilos DL, Leung DY, Wood R, et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 96:537-534, 1995.
12. Lee CH, Rhee CS, and Min YG. Cytokine gene expression in nasal polyps. Ann Otol Rhinol Laryngol 107:665-670, 1998.
13. Scott AE. Caution urged in treating steroid dependent anosmia. Otolaryngol Head Neck Surg 115:109-110, 1989.
14. Ogoshi T, and Usui N. Distribution of Tc 99m in human nasal cavity after use of Flunisolide nasal spray. Tokyo, Japan, XII ISIAN, Seoul, Korea Oct. 8-11, 1993.
15. Newman SP, Moren F, and Clark SW. The nasal distribution of metered dose inhalers. J Laryngol Otol 101:127-132, 1987.
16. Kennedy DW, Zinreich SJ, Rosenbaum AE, and Johns ME. Functional endoscopie sinus surgery: theory and diagnostic evaluation. Arch Otolaryngol 11:576-582, 1985.
17. Lund V, and Kennedy DW. Quantification for staging sinusitis. Ann Otol Rhinol Laryngol 104(suppl):10, 1995.
18. Bendtzen K. Cytokines and natural regulators of cytokines. Immunology Letters 42:111-123, 1994.
19. Hyams JS, Fitzgerald JE, Wyzga N, et al. Characterization of circulating interkukin-1 receptor antagonist expression in children with inflammatory bowel disease. Digestive Diseases and Sciences 39:1893-1899, 1994.
20. Sekiyama KM, Toshiba M, and Thompson AW. Circulating proinflammatory cytokines IL-IB, TNT-a, IL6, and IL-1 receptor antagonist (IL1-ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 98:71-77, 1994.
21. Schmidt E, Minnacht A, Schomig H, et al. Detection of IL-1a, IL-1B, and IL-1 receptor antagonist in blister fluid of bullous pemphigoid. J Dermatological Sci 11:142-147, 1996.
22. Ohlsson K, Bjork P, Bergenfeldt M, et al. Interleukin-1 receptor antagonist reduces mortality from endotoxic shock. Nature 348: 550-552, 1990.
23. Ackerman V, Marini M, Vittori E, et al. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Chest 105:687-696, 1994.
24. Hamilos DL, Leung DYM, and Wood R. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3. J Allergy Clin Immunol 92:39-48, 1993.
25. Ghamdi HA, Ghaffar O, Small P, et al. EL-4 and EL-13 expression in chronic sinusitis: relationship with cellular infiltrate and effect of topical corticosteroid treatment. J Otolaryngol 26:160-166, 1997.
26. Allison AC, and Eugi EM. Co-ordinate inhibition of the production of TNF, IL-1, and IL-6 by small molecules. Ann N Y Acad Sci 762:331-340; discussion 340-341, 1995.
27. Evans CH, and Robbins PD. The promise of a new clinical trial intra-articular IL-1 receptor antagonist. Proc Assoc Am Phys 108:1-5, 1996.
28. Sousa AR, Lane SJ, Nakhosteen JA, et al. Expression of interleukin-1 beta (IL-1B) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. Am J Respir Crit Care Med 154:1061-1066, 1996.